General

Showing 481–496 of 736 results

• 

  Article: New oncology reimbursements in Belgium

  €2.50 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €2.50 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €2.50 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €2.50 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €2.50 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €2.50 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €2.50 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €2.50 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €2.50 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €2.50 Add to cart
• 

  Article: Nivolumab improves survival in non-squamous NSCLC

  €2.50 Add to cart
• 

  Article: Nivolumab prolongs the survival of patients with advanced renal cell cancer

  €2.50 Add to cart
• 

  Article: Non-muscle myosin IIA, a new potential molecular target to improve radiotherapy outcome for breast cancer patients

  €2.50 Add to cart
• 

  Article: Not just a ‘usual’ Li-Fraumeni syndrome

  €2.50 Add to cart
• 

  Article: Novel therapeutic molecular targets in lung cancer: non-V600 mutant and mutant

  €2.50 Add to cart
• 

  Article: O.01 Circulating Tumour Cells and Survival in Abiraterone- and Enzalutamide-treated Patients with Castration-Resistant Prostate Cancer

  €2.50 Add to cart